US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

GEVA

(MM) (GEVA)

(MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GEVA

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
06/07/2015	11:14	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:GEVA	(MM)
29/06/2015	16:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GEVA	(MM)
24/06/2015	08:44	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:GEVA	(MM)
24/06/2015	05:06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GEVA	(MM)
23/06/2015	16:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GEVA	(MM)
23/06/2015	07:55	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GEVA	(MM)
23/06/2015	07:21	Edgar (US Regulatory)	(25-NSE)	NASDAQ:GEVA	(MM)
23/06/2015	07:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GEVA	(MM)
23/06/2015	05:30	Business Wire	Alexion Completes Acquisition of Synageva	NASDAQ:GEVA	(MM)
22/06/2015	07:54	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:GEVA	(MM)
22/06/2015	07:32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:GEVA	(MM)
22/06/2015	07:31	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:GEVA	(MM)
10/06/2015	10:32	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GEVA	(MM)
04/06/2015	15:05	PR Newswire (US)	Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC-103 for Mucopolysaccharidosis IIIB	NASDAQ:GEVA	(MM)
02/06/2015	18:29	Business Wire	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp.	NASDAQ:GEVA	(MM)
26/05/2015	15:05	PR Newswire (US)	Synageva BioPharma Submits Kanuma™ (Sebelipase Alfa) Application For LAL Deficiency In Japan	NASDAQ:GEVA	(MM)
22/05/2015	15:41	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:GEVA	(MM)
22/05/2015	15:31	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:GEVA	(MM)
22/05/2015	10:26	PR Newswire (US)	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp. -GEVA	NASDAQ:GEVA	(MM)
18/05/2015	15:10	PR Newswire (US)	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of Commencement of an Investigation...	NASDAQ:GEVA	(MM)
18/05/2015	13:28	Business Wire	SYNAGEVA BIOPHARMA CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Synageva BioPharma Corp. Over th...	NASDAQ:GEVA	(MM)
18/05/2015	11:18	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 4th Update	NASDAQ:GEVA	(MM)
18/05/2015	10:05	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd Update	NASDAQ:GEVA	(MM)
18/05/2015	08:20	Dow Jones News	Endo to Buy Par Pharma	NASDAQ:GEVA	(MM)
18/05/2015	07:53	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd Update	NASDAQ:GEVA	(MM)
18/05/2015	06:44	Dow Jones News	Endo to Buy Generics Maker Par Pharma for About $8 Billion -- Update	NASDAQ:GEVA	(MM)
13/05/2015	15:37	Business Wire	SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synageva BioPharma Corp. And Encourages ...	NASDAQ:GEVA	(MM)
11/05/2015	16:22	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:GEVA	(MM)
10/05/2015	12:03	The Motley Fool	Investors Just Doubled Their Money on This Stock	NASDAQ:GEVA	(MM)
10/05/2015	10:06	The Motley Fool	Will Suitors Line Up to Buy These Biotech Stocks Next?	NASDAQ:GEVA	(MM)

Showing the most relevant articles for your search:NASDAQ:GEVA

1 2 3 4 5 6 7 Próxima >

NLBNPIT1XCZ6 20351221 6....

Paragon 12 C1bs

Hsbc Usa Inc Capped Poin...

Drops Ownership Power

Bofa Finance Llc Autocal...

ITUBG338 Ex:32,24

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones